Patriot Financial Group Insurance Agency’s Acurx Pharmaceuticals ACXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-519
Closed -$8.45K 494
2024
Q4
$8.45K Hold
519
﹤0.01% 480
2024
Q3
$19.7K Hold
519
﹤0.01% 494
2024
Q2
$23.4K Hold
519
﹤0.01% 472
2024
Q1
$25.4K Buy
+519
New +$33.7K ﹤0.01% 473
2022
Q3
Sell
-488
Closed -$37K 424
2022
Q2
$37K Hold
488
0.01% 819
2022
Q1
$32K Buy
488
+138
+39% +$10.8K 0.01% 909
2021
Q4
$30K Buy
350
+150
+75% +$14.3K 0.01% 1054
2021
Q3
$21K Buy
+200
New +$20.6K ﹤0.01% 1183

Other funds holding ACXP

Patriot Financial Group Insurance Agency's ACXP Position: Q1 2025 in Review

Patriot Financial Group Insurance Agency sold out of Acurx Pharmaceuticals (ACXP) in Q1 2025, closing a stake of 519 shares — an estimated $8.45K sold.

Patriot Financial Group Insurance Agency first reported a position in ACXP in Q3 2021 and held it in 8 quarters. The position peaked at $37K in Q2 2022. 24 funds tracked by Wall St. Rank hold ACXP as of Q1 2025.

  • Patriot Financial Group Insurance Agency reported no remaining Acurx Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Patriot Financial Group Insurance Agency sold 519 Acurx Pharmaceuticals shares in Q1 2025, an estimated $8.45K.
  • Patriot Financial Group Insurance Agency first reported a position in Acurx Pharmaceuticals in Q3 2021 and held it in 8 quarters.
  • Patriot Financial Group Insurance Agency's Acurx Pharmaceuticals position peaked at $37K in Q2 2022.
  • 24 funds tracked by Wall St. Rank held Acurx Pharmaceuticals as of Q1 2025.

Based on Patriot Financial Group Insurance Agency's 13F filing for Q1 2025, filed 14 Apr 2025.